TY - JOUR AU - DeSantis, C. AU - Siegel, R. AU - Bandi, P. PY - 2011 DA - 2011// TI - Breast cancer statistics, 2011[J] JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20134 DO - 10.3322/caac.20134 ID - DeSantis2011 ER - TY - JOUR AU - Crown, J. AU - O'Leary, M. PY - 2000 DA - 2000// TI - The taxanes: an update[J] JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02074-2 DO - 10.1016/S0140-6736(00)02074-2 ID - Crown2000 ER - TY - JOUR AU - Gradishar, W. J. AU - Tjulandin, S. AU - Davidson, N. PY - 2005 DA - 2005// TI - Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer[J] JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.04.937 DO - 10.1200/JCO.2005.04.937 ID - Gradishar2005 ER - TY - JOUR AU - Ibrahim, N. K. AU - Desai, N. AU - Legha, S. PY - 2002 DA - 2002// TI - Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel[J] JO - Clin Cancer Res VL - 8 ID - Ibrahim2002 ER - TY - JOUR AU - Albain, K. S. AU - Nag, S. M. AU - Calderillo-Ruiz, G. PY - 2008 DA - 2008// TI - Gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment[J] JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.11.9362 DO - 10.1200/JCO.2007.11.9362 ID - Albain2008 ER - TY - JOUR AU - Roy, V. AU - LaPlant, B. R. AU - Gross, G. G. PY - 2009 DA - 2009// TI - Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531)[J] JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn661 DO - 10.1093/annonc/mdn661 ID - Roy2009 ER - TY - JOUR AU - Lobo, C. AU - Lopes, G. AU - Baez, O. PY - 2010 DA - 2010// TI - Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer[J] JO - Breast Cancer Res Treat VL - 123 UR - https://doi.org/10.1007/s10549-010-1002-0 DO - 10.1007/s10549-010-1002-0 ID - Lobo2010 ER - TY - JOUR AU - Desai, N. AU - Trieu, V. AU - Yao, Z. PY - 2006 DA - 2006// TI - Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel[J] JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1634 DO - 10.1158/1078-0432.CCR-05-1634 ID - Desai2006 ER - TY - JOUR AU - Gupta, R. AU - Toufaily, C. AU - Annabi, B. PY - 2014 DA - 2014// TI - Caveolin and cavin family members: dual roles in cancer[J] JO - Biochimie VL - 107 UR - https://doi.org/10.1016/j.biochi.2014.09.010 DO - 10.1016/j.biochi.2014.09.010 ID - Gupta2014 ER - TY - JOUR AU - El-Gendi, S. M. AU - Mostafa, M. F. AU - El-Gendi, A. M. PY - 2012 DA - 2012// TI - Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome[J] JO - Pathol Oncol Res VL - 18 UR - https://doi.org/10.1007/s12253-011-9469-5 DO - 10.1007/s12253-011-9469-5 ID - El-Gendi2012 ER - TY - JOUR AU - O'Shaughnessy, J. AU - Miles, D. AU - Vukelja, S. PY - 2002 DA - 2002// TI - Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results[J] JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.09.002 DO - 10.1200/JCO.2002.09.002 ID - O'Shaughnessy2002 ER - TY - JOUR AU - Untch, M. AU - Jackisch, C. AU - Schneeweiss, A. PY - 2016 DA - 2016// TI - Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial[J] JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(15)00542-2 DO - 10.1016/S1470-2045(15)00542-2 ID - Untch2016 ER - TY - JOUR AU - Sun, S. AU - Tang, L. AU - Zhang, J. PY - 2014 DA - 2014// TI - Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer[J] JO - Int J Nanomedicine VL - 9 ID - Sun2014 ER - TY - JOUR AU - Gradishar, W. J. AU - Krasnojon, D. AU - Cheporov, S. PY - 2009 DA - 2009// TI - Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer[J] JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.5397 DO - 10.1200/JCO.2008.18.5397 ID - Gradishar2009 ER - TY - JOUR AU - Tang, L. C. AU - Wang, B. Y. AU - Sun, S. PY - 2013 DA - 2013// TI - Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients[J] JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-232 DO - 10.1186/1471-2407-13-232 ID - Tang2013 ER - TY - JOUR AU - Sagara, Y. AU - Mimori, K. AU - Yoshinaga, K. PY - 2004 DA - 2004// TI - Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer[J] JO - Br J Cancer VL - 91 UR - https://doi.org/10.1038/sj.bjc.6602029 DO - 10.1038/sj.bjc.6602029 ID - Sagara2004 ER - TY - JOUR AU - Elsheikh, S. E. AU - Green, A. R. AU - Rakha, E. A. PY - 2008 DA - 2008// TI - Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype[J] JO - Br J Cancer VL - 99 UR - https://doi.org/10.1038/sj.bjc.6604463 DO - 10.1038/sj.bjc.6604463 ID - Elsheikh2008 ER - TY - JOUR AU - Pinilla, S. M. AU - Honrado, E. AU - Hardisson, D. PY - 2006 DA - 2006// TI - Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer[J] JO - Breast Cancer Res Treat VL - 99 UR - https://doi.org/10.1007/s10549-006-9184-1 DO - 10.1007/s10549-006-9184-1 ID - Pinilla2006 ER - TY - STD TI - Schubert W, Frank PG, Razani B, et al. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo[J]. J Biol Chem. 2001;276(52):48619–22. ID - ref19 ER - TY - JOUR AU - Tiruppathi, C. AU - Song, W. AU - Bergenfeldt, M. PY - 1997 DA - 1997// TI - Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway[J] JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.41.25968 DO - 10.1074/jbc.272.41.25968 ID - Tiruppathi1997 ER - TY - JOUR AU - Chatterjee, M. AU - Ben-Josef, E. AU - Robb, R. PY - 2017 DA - 2017// TI - Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy[J] JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-17-0604 DO - 10.1158/0008-5472.CAN-17-0604 ID - Chatterjee2017 ER - TY - JOUR AU - Witkiewicz, A. g. n. i. e. s. z. k. a. K. AU - Dasgupta, A. b. h. i. j. i. t. AU - Sotgia, F. e. d. e. r. i. c. a. AU - Mercier, I. s. a. b. e. l. l. e. AU - Pestell, R. i. c. h. a. r. d. G. AU - Sabel, M. i. c. h. a. e. l. AU - Kleer, C. e. l. i. n. a. G. AU - Brody, J. o. n. a. t. h. a. n. R. AU - Lisanti, M. i. c. h. a. e. l. P. PY - 2009 DA - 2009// TI - An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers JO - The American Journal of Pathology VL - 174 UR - https://doi.org/10.2353/ajpath.2009.080873 DO - 10.2353/ajpath.2009.080873 ID - Witkiewicz2009 ER -